Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Development of a cholera vaccination policy on the Island of Hispaniola, 2010-2013.

Vicari AS, Ruiz-Matus C, de Quadros C, Andrus JK.

Am J Trop Med Hyg. 2013 Oct;89(4):682-7. doi: 10.4269/ajtmh.13-0200.

2.

Use of oral cholera vaccine in Haiti: a rural demonstration project.

Ivers LC, Teng JE, Lascher J, Raymond M, Weigel J, Victor N, Jerome JG, Hilaire IJ, Almazor CP, Ternier R, Cadet J, Francois J, Guillaume FD, Farmer PE.

Am J Trop Med Hyg. 2013 Oct;89(4):617-24. doi: 10.4269/ajtmh.13-0183.

3.

Cholera vaccination campaign contributes to improved knowledge regarding cholera and improved practice relevant to waterborne disease in rural Haiti.

Aibana O, Franke MF, Teng JE, Hilaire J, Raymond M, Ivers LC.

PLoS Negl Trop Dis. 2013 Nov 21;7(11):e2576. doi: 10.1371/journal.pntd.0002576. eCollection 2013 Nov. Erratum in: PLoS Negl Trop Dis. 2013;7(12). doi:10.1371/annotation/13f018ff-b71a-4c5e-a276-d4b4ae608fee. Franke, Molly [corrected to Franke, Molly F]; Teng, Jessica [corrected to Teng, Jessica E].

4.

Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.

Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, Henry A, Tappero JW, Roels TH, Abrams J, Burkholder BT, Ruiz-Matus C, Andrus J, Dietz V.

Emerg Infect Dis. 2011 Nov;17(11):2105-12. doi: 10.3201/eid1711.110822.

5.

The case for reactive mass oral cholera vaccinations.

Reyburn R, Deen JL, Grais RF, Bhattacharya SK, Sur D, Lopez AL, Jiddawi MS, Clemens JD, von Seidlein L.

PLoS Negl Trop Dis. 2011 Jan 25;5(1):e952. doi: 10.1371/journal.pntd.0000952.

6.

Cholera vaccination in urban Haiti.

Rouzier V, Severe K, Juste MA, Peck M, Perodin C, Severe P, Deschamps MM, Verdier RI, Prince S, Francois J, Cadet JR, Guillaume FD, Wright PF, Pape JW.

Am J Trop Med Hyg. 2013 Oct;89(4):671-81. doi: 10.4269/ajtmh.13-0171.

7.

Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.

Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, Rath SB, Ali M, Mogasale V, Khuntia HK, Bhattachan A, You YA, Puri MK, Lopez AL, Maskery B, Nair GB, Clemens JD, Wierzba TF.

PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2629. doi: 10.1371/journal.pntd.0002629. eCollection 2014 Feb.

8.

Cholera elimination in Hispaniola.

Etienne CF, Tappero JW, Marston BJ, Frieden TR, Kenyon TA, Andrus JK.

Am J Trop Med Hyg. 2013 Oct;89(4):615-6. doi: 10.4269/ajtmh.13-0510. No abstract available.

9.

Modeling the effect of water, sanitation, and hygiene and oral cholera vaccine implementation in Haiti.

Fung IC, Fitter DL, Borse RH, Meltzer MI, Tappero JW.

Am J Trop Med Hyg. 2013 Oct;89(4):633-40. doi: 10.4269/ajtmh.13-0201. Erratum in: Am J Trop Med Hyg. 2013 Nov;89(5):1035.

10.

Can oral cholera vaccination play a role in controlling a cholera outbreak?

Calain P, Chaine JP, Johnson E, Hawley ML, O'Leary MJ, Oshitani H, Chaignat CL.

Vaccine. 2004 Jun 23;22(19):2444-51. Review.

PMID:
15193408
11.

Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.

von Seidlein L, Deen JL.

Emerg Infect Dis. 2012 Jul;18(7):1211-4. doi: 10.3201/eid1807.120071. No abstract available.

12.

First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.

Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, Dialo AA, Itama C, Serafini M, Legros D, Grais RF.

PLoS Negl Trop Dis. 2013 Oct 17;7(10):e2465. doi: 10.1371/journal.pntd.0002465. eCollection 2013.

13.

Oral Cholera Vaccine Coverage, Barriers to Vaccination, and Adverse Events following Vaccination, Haiti, 2013(1).

Tohme RA, Fran├žois J, Wannemuehler K, Iyengar P, Dismer A, Adrien P, Hyde TB, Marston BJ, Date K, Mintz E, Katz MA.

Emerg Infect Dis. 2015 Jun;21(6):984-91. doi: 10.3201/eid2106.141797.

14.

Public health. Policy shifts on emergency use of cholera vaccines.

Enserink M.

Science. 2012 Aug 17;337(6096):785-6. doi: 10.1126/science.337.6096.785. No abstract available.

PMID:
22903987
15.

Introducing cholera vaccination in Asia, Africa and Haiti: a meeting report.

Hall RH, Sack DA.

Vaccine. 2015 Jan 15;33(4):487-92. doi: 10.1016/j.vaccine.2014.11.031. Epub 2014 Nov 28.

PMID:
25437100
16.

Using Mobile Health (mHealth) and geospatial mapping technology in a mass campaign for reactive oral cholera vaccination in rural Haiti.

Teng JE, Thomson DR, Lascher JS, Raymond M, Ivers LC.

PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3050. doi: 10.1371/journal.pntd.0003050. eCollection 2014.

17.

When, how, and where can oral cholera vaccines be used to interrupt cholera outbreaks?

Clemens J, Holmgren J.

Curr Top Microbiol Immunol. 2014;379:231-58. doi: 10.1007/82_2013_353. Review.

PMID:
24402712
18.

Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo.

Merten S, Schaetti C, Manianga C, Lapika B, Chaignat CL, Hutubessy R, Weiss MG.

BMC Public Health. 2013 Jan 22;13:60. doi: 10.1186/1471-2458-13-60.

19.

Cholera vaccine plan splits experts.

Cyranoski D.

Nature. 2011 Jan 20;469(7330):273-4. doi: 10.1038/469273a. No abstract available.

PMID:
21248807
20.

Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.

Schaetti C, Weiss MG, Ali SM, Chaignat CL, Khatib AM, Reyburn R, Duintjer Tebbens RJ, Hutubessy R.

PLoS Negl Trop Dis. 2012;6(10):e1844. doi: 10.1371/journal.pntd.0001844. Epub 2012 Oct 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk